The prognosis of early relapsing or refractory aggressive non-Hodgkin's lymphoma (NHL) is still poor. Effective salvage therapy should be able to induce high response rate as well as to mobilize hematopoietic precursors. A combination of ifosfamide, epirubicin and etoposide (IEV) was given to 28 patients with refractory or relapsing high grade NHL (4 lymphoblastic lymphoma and 24 large cell lymphoma). All patients were evaluated for response. After 2 courses of IEV, the overall and complete response rate were 64% and 39%, respectively. All patients were controlled for mobilization of peripheral blood stem cells, which was successful in 26 out of 28 (93%). Overall, 25 out of 26 patients proceeded to autologous stem cell transplantation (ASCT). Toxicity was mild, with no occurrence of severe persisting extra-hematologic side-effects. Following the entire therapeutic program, including IEV and ASCT, median progression free survival has not yet been reached and 21 patients are alive (18 in continuous complete remission) after a median follow-up of 18 months. Our results demonstrate that treatment with IEV regimen is effective in refractory or relapsing aggressive NHL, resulting in a high percentage of successful stem cell mobilization and feasibility of ASCT.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/10428190410001683651 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Undifferentiated embryonal sarcoma of the liver masquerading as a cystadenoma in a young adult: a case report.
J Med Case Rep
November 2024
Department of Radiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310006, China.
Article Synopsis
- Undifferentiated embryonal sarcoma of the liver is a rare cancer mostly affecting children, and is even less common in adults; proper imaging is crucial to avoid misdiagnosing it with more common liver masses.
- A 37-year-old Chinese woman presented with abdominal pain and underwent multiple imaging tests revealing a cystic-solid liver nodule, initially thought to be benign.
- The definitive indication of malignancy came from a PET-CT scan, which showed abnormal F-fluorodeoxyglucose uptake, prompting the correct diagnosis of undifferentiated embryonal sarcoma of the liver.
A CARE-compliant article: A case report of retroperitoneal endometrial stromal sarcoma with multiple pulmonary metastases and literature review.
Medicine (Baltimore)
August 2024
First Department of Gynecology Oncology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences (Qingdao Central Hospital), Qingdao, China.
Rationale: Endometrial stromal sarcoma is an extremely rare mesenchymal neoplasm occurring in the extrauterine. Retroperitoneal endometrial stromal sarcoma with multiple pulmonary metastases, in particular, is extremely rare.
Patient Concerns: Forty-seven-year-old woman (gravida 3, para 2), was referred to our institution with complaints of fever.
Case report: Metastatic refractory undifferentiated small round-cell sarcoma successfully treated with surufatinib and camrelizumab.
Front Oncol
July 2024
Department of Oncology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, China.
Article Synopsis
- Undifferentiated small round-cell sarcomas (uSRCSs) are a tricky type of cancer to diagnose and treat, with no specific treatments available for advanced cases.
- A 37-year-old woman with advanced uSRCS tried several treatments that didn't work, including chemotherapy and a combination of other drugs.
- Finally, she responded well to a new treatment combining surufatinib and camrelizumab after many earlier treatments failed.
Analysis of three primary prostatic sarcoma cases and literature review.
Prostate
September 2024
Department of Urology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Article Synopsis
- * Doctors reviewed their medical records and found that two had stromal sarcoma and one had spindle cell sarcoma, which are types of high-grade cancers.
- * The researchers concluded that this cancer is very rare and usually doesn't have a good outcome, so early detection and treatment are super important, but recurrence is still a big risk even after treatment.
Assessment of the surface contamination of the primary packaging of oral antineoplastic drugs and secondary packaging of chemotherapy preparations at a Swiss hospital.
J Oncol Pharm Pract
May 2024
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), School of Pharmaceutical Sciences, University of Geneva, CMU, Geneva, Switzerland.
Introduction: Due to the high toxicity of antineoplastic drugs, handling their packaging could lead to the chemical contamination of hospital environments and exposure risks to healthcare professionals and patients. This study aimed to assess the contamination of two main surfaces: the outer primary packaging of oral antineoplastic drug formulations ( = 36) available on the Swiss market and the surface of secondary packaging of injectable antineoplastic drug preparations ( = 60) produced by the pharmacy of a Swiss hospital and carriers used for transport ( = 5).
Methods: Samples were collected using a validated wipe sampling method.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!